Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Tom A. Bäck Ajay K Gopal Oliver W Press |
| Publication date | August 11, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |